Investments (Tables)

12 Months Ended

Dec. 31, 2024

Investments [Abstract]

Schedule of Investment

	Equity investments accounted for using the equity method(i)			Equity investments without readily determinable fair values (ii)			Total
	US$			US$			US$
Balance as of December 31, 2022		5,799,737			869,918			6,669,655
Disposal		-			(353,062	)		(353,062	)
Share of gain in equity method investee		4,832			-			4,832
Foreign exchange translation		(165,593	)		(23,891	)		(189,484	)
Balance as of December 31, 2023		5,638,976			492,965			6,131,941
Additions		13,897,189			-			13,897,189
Transfer from the investment in subsidiary to equity investment		2,670,219			-			2,670,219
Share of gain in equity method investee		94,183			-			94,183
Foreign exchange translation		(390,525	)		(13,467	)		(403,992	)
Balance as of December 31, 2024		21,910,042			479,498			22,389,540

(i) Equity investments accounted for using equity method

(ii) Equity investments without readily determinable fair value

Schedule of Condensed Financial Information

The Company summarizes the condensed financial information of the Group’s equity investments in Jiangsu Guomai under equity method as below:

	For the years ended December 31,
	2024		2023		2022
	US$		US$		US$
Revenue		10,794,434		9,141,200		7,128,205
Gross profit		1,284,680		1,421,801		960,094
Net income (loss)		113,092		333,760		18,660

	December 31, 2024		December 31, 2023
	US$		US$
Current assets		13,208,065		3,417,004
Non-current assets		7,980,514		7,888,311
Total assets		21,188,579		11,305,315
Current liabilities		7,036,173		6,616,673
Non-Current liabilities		-		-
Total liabilities		7,036,173		6,616,673